Reminder - enSonix Professional Therapy Device Cleared With the FDA
Thursday October 19, 9:20 am ET
IRVINE, CA--(MARKET WIRE)--Oct 19, 2006 --
HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) is pleased to announce that another new product has been registered and cleared with the United States Food and Drug Administration (FDA). The enSonix Professional treatment device is also a class one device and has been indicated for pain reduction and muscle relaxation.
ADVERTISEMENT
"enSonix Professional is specifically targeted at healthcare and rehabilitation specialists. Our goal is to make enSonix therapy a cornerstone treatment in the fight against the pain of arthritis. Medical professionals will now have access to this exciting new technology to use in hospitals and rehabilitation facilities," said Dieter Doederlein, Vice President of Corporate Development. "Arthritis is the number one cause of chronic pain in North America and our breakthrough medical technology is very timely with the aging of the population." enSonix Professional system will be available for commercial shipments in the first quarter of 2007.
The sound pressure waves generated by the enSonix@home medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and they increase blood circulation.
About HealthSonix, Inc.
HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.
More information regarding HealthSonix and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
Contact:
Dieter D. Doederlein
1-877-622-2121
info@healthsonix.com
**************************************************
Wer verscherbelt denn da seine Aktien so billig *g* ?
Zurück
Weiter
